Nozawa T, Yasumura Y, Futaki S, Tanaka N, Suga H
Department of Cardiovascular Dynamics, National Cardiovascular Center Research Institute, Osaka, Japan.
Am J Physiol. 1988 Oct;255(4 Pt 2):H807-12. doi: 10.1152/ajpheart.1988.255.4.H807.
In the cross-circulated dog hearts arrested with KCl, we examined the effects of left ventricular volume and dobutamine on the resting oxygen consumption (MVO2). The perfusion pressure of the excised heart was stable under the cross-circulation for 1-1.5 h with a dialyzer to normalize coronary venous KCl despite continuous coronary arterial injection of KCl. The resting MVO2 declined gradually during the first 10 min of cardiac arrest but changed little thereafter. The resting MVO2 at 5 min and 30 min of arrest were 30.5 +/- 9.3 (SD) and 23.8 +/- 12.9%, respectively, of unloaded MVO2 before arrest. The resting MVO2 after its stabilization was 1.02 +/- 0.42 ml O2.min-1.100 g ventricle-1 in the control. It was 1.12 +/- 0.48 ml O2.min-1.100 g ventricle-1 under a continuous infusion of dobutamine at rate of 10-25 micrograms/min. This change with dobutamine was statistically insignificant. The resting MVO2 was not affected by changes in left ventricular volume both before and under dobutamine. The present result implies that MVO2 for basal metabolism in a working dog heart is virtually constant regardless of ventricular volume and contractility.
在使用氯化钾使心脏停搏的交叉循环犬心脏中,我们研究了左心室容积和多巴酚丁胺对静息氧耗量(MVO2)的影响。尽管持续向冠状动脉内注射氯化钾,但使用透析器使冠状静脉氯化钾正常化后,离体心脏在交叉循环下灌注压力稳定1 - 1.5小时。心脏停搏的最初10分钟内静息MVO2逐渐下降,但此后变化不大。停搏5分钟和30分钟时的静息MVO2分别为停搏前无负荷MVO2的30.5±9.3(标准差)和23.8±12.9%。稳定后的静息MVO2在对照组中为1.02±0.42毫升氧·分钟-1·100克心室-1。在以10 - 25微克/分钟的速率持续输注多巴酚丁胺的情况下,其为1.12±0.48毫升氧·分钟-1·100克心室-1。多巴酚丁胺引起的这种变化在统计学上无显著意义。静息MVO2在多巴酚丁胺使用前和使用过程中均不受左心室容积变化的影响。目前的结果表明,工作犬心脏基础代谢的MVO2实际上是恒定的,与心室容积和收缩性无关。